Drug intelligence / Profile preview

indium oxine

Development stage
Approved
Lead developer
GE Healthcare
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Administration
Intravenous
01

Overview

**Indium oxine** is a radiopharmaceutical agent composed of a neutral, lipid-soluble complex formed by the coordination of three molecules of 8-hydroxyquinoline (oxine) with the radioactive isotope indium-111. Its primary use is in nuclear medicine for the radiolabeling of leukocytes (white blood cells) to facilitate scintigraphic imaging of sites of inflammation, abscess, or infection. Following intravenous administration, the complex penetrates cell membranes, after which indium-111 dissociates and binds to cytoplasmic components, enabling its retention within the cells. The indium-111 isotope emits gamma rays (171 and 245 keV) that can be detected by gamma cameras, supporting diagnostic imaging. Indium oxine is used especially for localizing inflammatory processes to which leukocytes migrate and is also employed for labeling platelets to detect thrombi. The molecular formula is C27H18InN3O3.

Brand names
Indium In 111 Oxyquinoline
Other names
indium oxinatetris(oxinato)indiumtris(8-hydroxyquinolinato)indium

Beyond the preview

Go deeper on indium oxine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on indium oxine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call